Background—Emerging studies suggest that early administration of dual antiplatelet therapy
may be better than monotherapy for prevention of early recurrent stroke and cardiovascular …

Background and Purpose—Antiplatelets are recommended for patients with acute
noncardioembolic stroke or transient ischemic attack. We compared the safety and efficacy …

Background Aspirin is recommended for secondary prevention after transient ischaemic
attack (TIA) or ischaemic stroke on the basis of trials showing a 13% reduction in long-term …

Background: Dual antiplatelet treatment (DAPT) with aspirin plus clopidogrel for a limited
time is recommended after minor noncardioembolic stroke. Methods: We performed a meta …

Background and Purpose—Predictors of stroke and transient ischemic attack (TIA) in
patients with peripheral artery disease (PAD) are poorly understood. The primary aims of …

Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke
remain unacceptably high. To address this issue, one potential target for novel therapeutics …

Background New evidence on the efficacy and safety of dual antiplatelet therapy for
secondary stroke prevention have been realized in the recent years. An updated meta …

Background Stroke is a leading cause of morbidity and mortality worldwide. Antiplatelet
agents are considered to be the cornerstone for secondary prevention of stroke, but the role …

Objective Recent years have seen new evidence on the efficacy and safety of dual
antiplatelet therapy for secondary stroke prevention. We updated a meta-analysis of …

Objective—To investigate whether adenosine diphosphate (ADP)–derived adenosine might
inhibit platelet aggregation, especially in the presence of a P2Y12 antagonist, where the …